Skip to main content

Table 1 Demographics and aneurysm characteristics of patients

From: Pipeline versus Tubridge in the treatment of unruptured posterior circulation aneurysms

 

Total n = 107

PED n = 55

TFD n = 52

P-value

Gender (n, %)

   

0.696

 Male

80 (74.8)

42 (76.4)

38 (73.1)

 

 Female

27 (25.2)

13 (23.6)

14 (26.9)

 

Age (mean ± SD)

55.2 ± 10.0

53.4 ± 9.6

57.0 ± 10.2

0.063

Clinical presentation (n, %)

   

0.117

 Headache or dizziness

48 (44.9)

30 (54.5)

18 (34.6)

 

 Ischemic symptom

7 (6.5)

3 (5.5)

4 (7.7)

 

 Incidentally found

52 (48.6)

22 (40.0)

30 (57.7)

 

Hypertension (n, %)

69 (64.5)

33 (60.0)

36 (69.2)

0.319

Diabetes (n, %)

11 (10.3)

5 (9.1)

6 (11.5)

0.677

Multiple aneurysms (n, %)

8 (7.5)

6 (10.9)

2 (3.8)

0.165

Location (n, %)

   

0.999

 Vertebral artery

83 (77.6)

43 (78.2)

40 (76.9)

 

 Basilar artery

16 (15.0)

8 (14.5)

8 (15.4)

 

 Vertebrobasilar artery

6 (5.6)

3 (5.5)

3 (5.8)

 

 Others

2 (1.9)

1 (1.8)

1 (1.9)

 

Morphology (n, %)

   

0.281

 Saccular

32 (29.9)

19 (34.5)

13 (25.0)

 

 Fusiform

75 (70.1)

36 (65.5)

39 (75.0)

 

Maximum dimeter (mean ± SD)

11.8 ± 7.1

11.8 ± 7.2

11.8 ± 7.0

0.981

Size (n, %)

   

0.499

 Small (< 5 mm)

4 (3.7)

1 (1.8)

3 (5.8)

 

 Medium (5–10 mm)

53 (49.5)

29 (52.7)

24 (46.2)

 

 Large/giant (> 10 mm)

50 (46.7)

25 (45.5)

25 (48.1)

 
  1. PED Pipeline embolization device, TFD Tubridge flow diverter, SD Standard deviation